Anti-EGFRvIII Chimeric Antigen Receptor-Modified T Cells for Adoptive Cell Therapy of Glioblastoma

By  

Current Pharmaceutical Design, Vol. 23, Iss. 14, 2017-05 ,pp. : 2113-2116

Bentham Science Publishers

Access to resources Recommend Favorite

CD6 as a Cell Surface Receptor and As a Target for Regulating Immune Responses

By  

Current Drug Targets, Vol. 17, Iss. 6, 2016-05 ,pp. : 619-629

Bentham Science Publishers

Access to resources Recommend Favorite

Apoptosis Suppression by Candidate Oncogene PLAC8 is Reversed in Other Cell Types

By  

Current Cancer Drug Targets, Vol. 13, Iss. 1, 2013-01 ,pp. : 80-91

Bentham Science Publishers

Access to resources Recommend Favorite

Types of Programmed Cell Death: Two Variants Expressed by Neonatal Murine Hepatocytes

By  

Cells Tissues Organs, Vol. 175, Iss. 1, 2003-11 ,pp. : 34-42

Karger

Access to resources Recommend Favorite

Lysophosphatidic acid acyltransferase-β: a novel target for induction of tumour cell apoptosis

By Bonham Lynn   Leung David W   White Thayer   Hollenback David   Klein Peter   Tulinsky John   Coon Michael   de Vries Peter   Singer Jack W  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 5, 2003-10 ,pp. : 643-661

Informa Healthcare

Access to resources Recommend Favorite